Krebs Biochem

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE268B01013
NSEID: KREBSBIO
BSEID: 524518

INR

73.81

2.81 (3.96%)

BSENSE

Apr 11, 12:16 PM

BSE+NSE Vol: 2.64 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2024 is -11.63% vs 42.79% in Dec 2023

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -55.42% vs 10.27% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is -125.36% vs 30.10% in Dec 2023

Interest

YoY Growth in quarter ended Dec 2024 is 31.09% vs 32.22% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023

Compare Quarterly Results Of Krebs Biochem With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

11.47

2,396.57

-2,385.10

-99.52%

Other Operating Income

0.00

Total Operating income

11.47

2,396.57

-2,385.10

-99.52%

Raw Material Cost

1.19

179.72

-178.53

-99.34%

Purchase of Finished goods

0.00

445.60

-445.60

-100.00%

(Increase) / Decrease In Stocks

0.12

34.08

-33.96

-99.65%

Employee Cost

4.50

521.79

-517.29

-99.14%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

10.37

474.45

-464.08

-97.81%

Total Expenditure (Excl Depreciation)

16.18

1,655.64

-1,639.46

-99.02%

Operating Profit (PBDIT) excl Other Income

-4.71

740.93

-745.64

-100.64%

Other Income

0.25

69.82

-69.57

-99.64%

Operating Profit (PBDIT)

-4.46

810.75

-815.21

-100.55%

Interest

1.56

199.47

-197.91

-99.22%

Exceptional Items

0.00

Gross Profit (PBDT)

-6.02

611.28

-617.30

-100.98%

Depreciation

1.72

87.03

-85.31

-98.02%

Profit Before Tax

-7.74

524.25

-531.99

-101.48%

Tax

0.00

107.87

-107.87

-100.00%

Provisions and contingencies

0.00

Profit After Tax

-7.74

416.38

-424.12

-101.86%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

-7.74

416.38

-424.12

-101.86%

Equity Capital

21.56

40.06

-18.50

-46.18%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

-3.59

10.39

-13.98

-134.55%

Diluted Earnings per share

-3.59

10.33

-13.92

-134.75%

Operating Profit Margin (Excl OI)

-41.06%

30.92%

0.00

-71.98%

Gross Profit Margin

-52.48%

25.51%

0.00

-77.99%

PAT Margin

-67.48%

17.37%

0.00

-84.85%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 11.47 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -10.81% vs -0.23% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -11.63% vs 42.79% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit -7.74 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -34.38% vs -11.41% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -55.42% vs 10.27% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) -4.71 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -73.80% vs -23.18% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -125.36% vs 30.10% in Dec 2023

Quarterly - Interest

Interest 1.56 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 9.86% vs 7.58% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 31.09% vs 32.22% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) -41.06%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023